2018
DOI: 10.1016/j.snb.2018.06.064
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous fluorescence imaging monitoring of the programmed release of dual drugs from a hydrogel-carbon nanotube delivery system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 50 publications
(23 citation statements)
references
References 43 publications
0
23
0
Order By: Relevance
“…For instance, by loading doxorubicin in chitosan‐coated carbon nanotubes and incorporating rhodamine B in the hydrogel matrix comprised by polycaprolactone‐polyethylene glycol‐polycaprolactone, researchers have demonstrated spatiotemporal programming of the two drugs. [ 59 ] At physiological conditions (pH ≈ 7.4), this platform showed distinct release rates with higher cumulative release of rhodamine B followed by doxorubicin, the latter which significantly enhanced its release rate when exposed to acidic conditions, unlike rhodamine B that maintained its passive diffusion‐mediated release kinetics. As showcased, designing nanocomposite hydrogels benefits from the added flexibility and ease for incorporating different bioactive compounds as well as encoding multimodal release rates to the meet the specifications of each drug and potentiate their effect.…”
Section: Stimuli‐responsive Nanocomposite Hydrogels and Biomedical Apmentioning
confidence: 99%
“…For instance, by loading doxorubicin in chitosan‐coated carbon nanotubes and incorporating rhodamine B in the hydrogel matrix comprised by polycaprolactone‐polyethylene glycol‐polycaprolactone, researchers have demonstrated spatiotemporal programming of the two drugs. [ 59 ] At physiological conditions (pH ≈ 7.4), this platform showed distinct release rates with higher cumulative release of rhodamine B followed by doxorubicin, the latter which significantly enhanced its release rate when exposed to acidic conditions, unlike rhodamine B that maintained its passive diffusion‐mediated release kinetics. As showcased, designing nanocomposite hydrogels benefits from the added flexibility and ease for incorporating different bioactive compounds as well as encoding multimodal release rates to the meet the specifications of each drug and potentiate their effect.…”
Section: Stimuli‐responsive Nanocomposite Hydrogels and Biomedical Apmentioning
confidence: 99%
“…The difference of drug loading is pointed out as the source of the observed release rate. Furthermore, pH dependency was also noticed [98]. CNT based-hydrogels could also find applications in cancer therapy: Hindumathi et al confined CNT inside a PEG cocoon in order to load drugs such as curcumin, allowing curcumin cellular uptake [99].…”
Section: Cnt-based Hydrogels For Biomedical Applicationsmentioning
confidence: 99%
“…Balb/c nude mice were subcutaneously administered with RB-DOX-CNTs/hydrogel and tracked by a multispectral fluorescence imaging system. Among the tested anti-cancer drugs, DOX exerted a significantly slower release rate vs. RB rate from hydrogel, affirming the system may prove a potential NDDP with programmed release of anti-cancer drugs in combined drug administration therapy for treatment of cancer [ 52 ]. Karthika et al (2018) [ 53 ] designed MWCNTs TiO 2 -Au to enhance the biocompatibility of NDDP for in vitro DOX delivery.…”
Section: Inorganic Nddps Implicated In Anti-cancer Therapymentioning
confidence: 99%